Molnupiravir represents a important development in the battle against COVID-19, functioning as an oral antiviral drug. First designed to combat influenza, its unique mechanism of action – introducing errors into the SARS-CoV-2's genetic code – has demonstrated efficacy in reducing the risk of severe illness and hospitalization in some individua